title: [Antibiotic therapy in secondary peritonitis: towards a definition of its optimal duration].
abstract: BACKGROUND
  The optimal time period of antibiotic treatment in secondary peritonitis is still unknown.
  
  
  OBJECTIVE
  To prospectively evaluate: 1) The preferred time period of antibiotic treatment in secondary peritonitis by means of a survey applied to a sample of surgeons, and 2) The outcome of a series of patients with secondary peritonitis in whom the length of antibiotic treatment was based on clinical and laboratory indicators.
  
  
  METHODS
  A survey presenting the case of a patient with acute appendicitis and secondary peritonitis was applied to 100 Mexican surgeons. The optimal length of antibiotic treatment in that particular patient was asked. Results were tabulated and analyzed. Subsequently, 35 patients with secondary peritonitis were prospectively evaluated. Antibiotics were discontinued when fever relapsed and the white blood count normalized. Clinical characteristics, diagnosis, surgical treatment and outcome were analyzed. Recurrence of sepsis was investigated as the main outcome variable.
  
  
  RESULTS
  The survey revealed that 96% surgeons recommended antibiotic treatment for a period longer than one week. In our study group median age was 33 years, 21 were male and 14 female. All patients had a surgical abdominal condition associated to secondary peritonitis. Median period of antibiotic treatment was 3 days. In a follow-up of one month there was no persistent or recurrent sepsis in any patient.
  
  
  CONCLUSIONS
  This information may impact in determining the total length of antibiotic therapy if our results are reproduced in studies with more patients.
authors: Departamento de Cirugía, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F.
authors: F
authors: F
authors: Alcocer
authors: E
authors: E
authors: López
authors: J J
authors: JJ
authors: Calva
authors: M F
authors: MF
authors: Herrera
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use*; D002648:Child; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D010818:Practice Patterns, Physicians'
chemical_list: D000900:Anti-Bacterial Agents